AUPQ916200A0 - Novel peptides for development of diagnostic and therapeutic agents and methods of using same - Google Patents

Novel peptides for development of diagnostic and therapeutic agents and methods of using same

Info

Publication number
AUPQ916200A0
AUPQ916200A0 AUPQ9162A AUPQ916200A AUPQ916200A0 AU PQ916200 A0 AUPQ916200 A0 AU PQ916200A0 AU PQ9162 A AUPQ9162 A AU PQ9162A AU PQ916200 A AUPQ916200 A AU PQ916200A AU PQ916200 A0 AUPQ916200 A0 AU PQ916200A0
Authority
AU
Australia
Prior art keywords
diagnostic
development
methods
same
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ9162A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prince Henrys Institute of Medical Research
Original Assignee
Prince Henrys Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prince Henrys Institute of Medical Research filed Critical Prince Henrys Institute of Medical Research
Priority to AUPQ9162A priority Critical patent/AUPQ916200A0/en
Publication of AUPQ916200A0 publication Critical patent/AUPQ916200A0/en
Priority to DE60043782T priority patent/DE60043782D1/en
Priority to PCT/AU2000/001258 priority patent/WO2001029079A1/en
Priority to EP09004549A priority patent/EP2112159A3/en
Priority to EP00971123A priority patent/EP1226166B1/en
Priority to NZ518320A priority patent/NZ518320A/en
Priority to CA2387576A priority patent/CA2387576C/en
Priority to AU10078/01A priority patent/AU782490B2/en
Priority to CA2642066A priority patent/CA2642066C/en
Priority to DK00971123.5T priority patent/DK1226166T3/en
Priority to AT00971123T priority patent/ATE456575T1/en
Priority to US10/125,187 priority patent/US7511123B2/en
Priority to US12/414,180 priority patent/US8399202B2/en
Abandoned legal-status Critical Current

Links

AUPQ9162A 1999-10-18 2000-08-03 Novel peptides for development of diagnostic and therapeutic agents and methods of using same Abandoned AUPQ916200A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AUPQ9162A AUPQ916200A0 (en) 2000-08-03 2000-08-03 Novel peptides for development of diagnostic and therapeutic agents and methods of using same
AT00971123T ATE456575T1 (en) 1999-10-18 2000-10-18 IMMUNE-INTERACTIVE FRAGMENTS OF THE ALPHA-C SUBUNIT OF INHIBIN
CA2387576A CA2387576C (en) 1999-10-18 2000-10-18 Immuno-interactive fragments of the .alpha.c subunit of inhibin
PCT/AU2000/001258 WO2001029079A1 (en) 1999-10-18 2000-10-18 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN
EP09004549A EP2112159A3 (en) 1999-10-18 2000-10-18 Immuno-interactive fragments of the alpha C subunit of inhibin
EP00971123A EP1226166B1 (en) 1999-10-18 2000-10-18 Immuno-interactive fragments of the alpha c subunit of inhibin
NZ518320A NZ518320A (en) 1999-10-18 2000-10-18 Immuno-interactive fragments of the alphaC subunit of inhibin
DE60043782T DE60043782D1 (en) 1999-10-18 2000-10-18 IMMUNE-INTERACTIVE FRAGMENTS OF THE ALPHA C SUB-UNIT OF INHIBIN
AU10078/01A AU782490B2 (en) 1999-10-18 2000-10-18 Immuno-interactive fragments of the alphaC subunit of inhibin
CA2642066A CA2642066C (en) 1999-10-18 2000-10-18 Immuno-interactive fragments of the .alpha.c subunit of inhibin
DK00971123.5T DK1226166T3 (en) 1999-10-18 2000-10-18 Immune-interacting fragments of the alpha C subunit of inhibin
US10/125,187 US7511123B2 (en) 1999-10-18 2002-04-18 Immuno-interactive fragments of the alpha-C subunit of inhibin
US12/414,180 US8399202B2 (en) 1999-10-18 2009-03-30 Peptides for development of diagnostic and therapeutic agents and methods of using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ9162A AUPQ916200A0 (en) 2000-08-03 2000-08-03 Novel peptides for development of diagnostic and therapeutic agents and methods of using same

Publications (1)

Publication Number Publication Date
AUPQ916200A0 true AUPQ916200A0 (en) 2000-08-24

Family

ID=3823220

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ9162A Abandoned AUPQ916200A0 (en) 1999-10-18 2000-08-03 Novel peptides for development of diagnostic and therapeutic agents and methods of using same

Country Status (1)

Country Link
AU (1) AUPQ916200A0 (en)

Similar Documents

Publication Publication Date Title
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
AU9383098A (en) Novel targeted contrast agents for diagnostic and therapeutic use
AU3683800A (en) Device for the therapeutic and cosmetic photo-processing of biological tissues and method for using the same
IL153970A0 (en) Promyostatin peptides and methods of using same
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
IL153824A0 (en) Method and kit for diagnosis of diseases
AU6894700A (en) Therapeutic polypeptides and methods for using same
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU2001289308A1 (en) Targeted agents useful for diagnostic and therapeutic applications
AU2002952993A0 (en) Therapeutic and diagnostic agents
AU3622600A (en) Metalloproteinases and methods of use therefor
IL154128A0 (en) Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU5836700A (en) Peptides for therapeutic use
AUPQ916200A0 (en) Novel peptides for development of diagnostic and therapeutic agents and methods of using same
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2001249608A1 (en) Bladder cancer-specific peptides for diagnosis and therapy
AUPQ348599A0 (en) Novel peptides for development of diagnostic and therapeutic agents and methods of using same
AU2001271281A1 (en) Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
AU2001284651A1 (en) Secreted proteins and methods of using same
AUPQ599500A0 (en) Novel peptides, modulatory agents therefor and methods of using them
AU3863900A (en) Prolyl peptidases and methods of use
SG90719A1 (en) Novel therapeutic and prophylactic agents and methods of using same

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 1007801

Country of ref document: AU